Lorus Therapeutics Announces Proposed Rights Offering and Financing Commitment
TORONTO, ONTARIO--(Marketwire - Aug. 30, 2010) - Lorus Therapeutics Inc. (TSX:LOR)(OTCBB:LRUSF) ("Lorus" or the "Company") today announced that due to unfavorable market conditions the board of directors of Lorus has decided that the Company will not be proceeding with its previously announced public equity offering. In lieu thereof Lorus is intending to do a shareholder rights offering.
